HOME >> MEDICINE >> NEWS
First new treatment for alcoholism in ten years, now available Campral(R) (acamprosate calcium)

NEW YORK, Jan. 11--Forest Laboratories, Inc. announced today that Campral(R) (acamprosate calcium) Delayed- Release Tablets are now available to physicians, patients and pharmacies nationwide. Campral was approved by the U.S. Food and Drug Administration (FDA) on July 29, 2004 for the maintenance of abstinence from alcohol in patients with alcohol dependence who are abstinent at treatment initiation. Treatment with Campral should be part of a comprehensive management program that includes psychosocial support. The approval of Campral was the first in nearly ten years of a treatment for alcohol dependence.

"We believe that Campral, in combination with psychosocial support, sets a new standard for treating the chronic disease of alcoholism," said Howard Solomon, Chairman and Chief Executive Officer of Forest Laboratories. "Forest is committed to providing an effective and safe drug therapy to help the millions of Americans struggling with alcohol-dependence to maintain abstinence."

Campral and Complete Abstinence

"A major treatment goal for alcohol dependence is to increase rates of abstinence," said Barbara Mason, Ph.D., Professor of Neuropharmacology, Co- Director of The Pearson Center for Alcoholism and Addiction Research, The Scripps Research Institute. "Campral, when used in combination with psychosocial support, can help committed patients reach this goal because it is thought to help restore the brain's chemical balance that has been disrupted by long-term excessive drinking."

The mechanism of action of Campral in maintenance of alcohol abstinence is not completely understood. Chronic alcohol exposure is hypothesized to alter the normal balance between neuronal excitation and inhibition.(1) Campral interacts with neurotransmitter systems and is hypothesized to restore the normal balance.(1) This mechanism of action is different from that ascribed to currently available medications, which either b
'"/>


11-Jan-2005


Page: 1 2 3

Related medicine news :

1. First head-to-head study to compare lidoderm patch and Celebrex in treating pain
2. First UK cases of previously rare disease reported in gay men
3. First mouse model for multiple system atrophy points to new treatment targets for brain diseases
4. Mayo Clinic researchers create obedient virus; First step to use measles virus against cancer
5. First US kidney cancer vaccine trial underway at Columbia
6. First blood test to diagnose paralyzing, blinding disease
7. First US SARS vaccine trial opens at NIH
8. First-ever safety study of medical cannabis use in Canada launched
9. First solid evidence that the study of music promotes intellectual development
10. First medical test on CD gets good results
11. First proof that cutting Rx drugs due to cost harms health

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/16/2018)... ... ... dicentra Global Certifications, an affiliate of dicentra Cannabis Consulting, has announced the release of ... country in the world to formally legalize the recreational production and use of cannabis. ... use of cannabis edibles. , More than one in four Canadians aged 25 to ...
(Date:10/16/2018)... ... October 15, 2018 , ... LGC Maine Standards ... Number 205bf, for easier linearity and calibration verification. , The kit, in ... verification and verification of the reportable range for Albumin (ALB), Amylase (AMY), Cholesterol ...
(Date:10/16/2018)... ... October 16, 2018 , ... ... clinical research networking-technology company founded by patient-survivors, and The Avoca Group, Inc., ... the clinical trial execution process, today announced its mutual collaboration that will ...
(Date:10/13/2018)... ... October 12, 2018 , ... Convoy of Hope’s Disaster Services Team ... has a distribution site set up to serve hurricane survivors with water, food, baby ... Up to 50 additional truckloads of supplies are in motion to Florida. , ...
(Date:10/11/2018)... ... October 11, 2018 , ... Cognosante, ... of J.Lodge, an industry leader in contact center monitoring and quality assurance. ... debilitating medical condition—J. Lodge supports alternative work environments and flexible schedules, providing remote ...
Breaking Medicine News(10 mins):
(Date:10/17/2018)... ... October 17, 2018 , ... The OMNISteth™ is ... video conferencing platform and intuitive adjustments maximize the sound quality and performance during ... auscultation area on the body, which automatically adjusts the listening frequency range to ...
(Date:10/16/2018)... ... October 16, 2018 , ... Citrus Valley Health Partners ... an exciting and inclusive forum on the health care ecosystem of the San Gabriel ... designed to foster evidence-based dialogues and actionable solutions aimed at transforming the way health ...
(Date:10/16/2018)... , ... October 16, 2018 , ... Cameras and monitoring ... of the home where safety plays a key role in a family’s health and ... of “Today’s Homeowner” TV hosted a “Safe At Home” satellite media event today. ...
Breaking Medicine Technology:
Cached News: